Biotie Therapies - Total number of voting rights and capital

Change in the number of votes relating to Biotie Therapies Corp.'s shares

BIOTIE THERAPIES CORP.                  Stock Exchange Release            23
April 2015 at 10.45 am

Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares, that were issued on 17 December 2014, pursuant to the
Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans") as
follows:

 Shares conveyed Cumulative shares conveyed      Remaining shares to be
                 since 17 December  2014         conveyed

 244,250         1,821,125                       626,250


Under the Stock Option Plan 2011, the owners of the stock options may subscribe
for a maximum total of 7,401,000 new shares in the Company or existing shares
held by the Company, of which a total of 1,844,250 were subscribed for in 2014.
A total of 94,250 shares have been subscribed for during the period 27 February
2015 and 22 April 2015 and 94,250 of the treasury shares will be used for these
share subscriptions. The subscription price of EUR 0.01 per share has been fully
paid by the employee and the EUR 942.50 funds received will be credited to the
Company's reserve for non-restricted equity. Due to share issues already made
pursuant to the Stock Option Plan 2011, forfeitures and some of the instruments
based on the plan having been left unallocated, a maximum of 1,291,875 shares
may still be issued pursuant to the Stock Option Plan 2011.

The second vesting period of the Equity Incentive Plan 2011 ended on 5 January
2015, after which the Company's shares shall be delivered to employees on the
basis of the granted share units. It was resolved pursuant to the authorization
of the Annual General Meeting of the Shareholders held on 3 April 2014 to issue
150,000 existing treasury shares to the employees without consideration for the
purposes of remunerating the employees pursuant to the terms and conditions of
the Equity Incentive Plan 2011 and thus, there is an especially weighty
financial reason to derogate from the pre-emptive right of the shareholders, as
referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as
amended). Due to share issues already made pursuant to the Equity Incentive Plan
2011, forfeitures and some of the instruments based on the plan having been left
unallocated, a maximum of 697,500 shares may still be issued pursuant to the
Equity Incentive Plan 2011.

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:

 Increase in number of      Total amount of Number of the         Total number
 outstanding shares         voting rights   Company's shares held of registered
                                            by the Group          shares

 244,250                    452,601,484     3,366,690             455,968,174


Turku, 23 April 2015

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
www.biotie.com

DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media


[HUG#1913807]